Diagnosis of cardiac amyloidosis as indicated by the criteria set forth in guidelines such as in Kittleson et al: "2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis: A Report of the American College of Cardiology Solution Set Oversight Committee
Implanted Cardiac Pacemaker (+/- Defibrillator)
Pacemaker mode of AAI or DDD if in sinus rhythm, VVI acceptable if permanent atrial fibrillation
Non-dilated left ventricle by echocardiography
Ability to provide written consent
English Speaking
You may not be if
Paced QRS duration of \>150 ms (indicator for pacing mediated dyssynchrony)